JUAN PLANA GOMEZ to Trastuzumab
This is a "connection" page, showing publications JUAN PLANA GOMEZ has written about Trastuzumab.
Connection Strength
0.160
-
Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014 Mar 04; 63(8):809-16.
Score: 0.024
-
Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging. 2014 Mar; 15(3):324-31.
Score: 0.024
-
Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr. 2013 May; 26(5):493-8.
Score: 0.023
-
Cardioprotective effect of ?-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure. Circ Heart Fail. 2013 May; 6(3):420-6.
Score: 0.023
-
Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013 Jan 08; 61(1):77-84.
Score: 0.023
-
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012 Sep 01; 5(5):596-603.
Score: 0.022
-
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011 May 01; 107(9):1375-80.
Score: 0.020